Special Issue "Health-Economic Evaluation and Value-Based Health Care"
A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Health Economics".
Deadline for manuscript submissions: closed (30 September 2023) | Viewed by 1484
Special Issue Editors
Interests: health economics; health policy; health technology assessment; real-world study
Interests: health economics; health policy; health technology assessment; real-world study
Special Issue Information
Dear Colleagues
Chronic diseases, which are broadly defined as illnesses that last for more than 1 year, are the leading causes of death and disability around the world. Chronic diseases include heart disease, stroke, cancer, diabetes, arthritis, and other conditions. Traditionally, chronic diseases have been considered as ‘diseases of affluence’ that mainly affect older adults in developed regions and countries. This traditional view has prevailed in economic evaluations and assessments of clinical outcomes, partially due to the lack of up-to-date research looking into the economic and clinical burden of chronic diseases, even though recent reports have strongly suggested an increase in the prevalence of chronic diseases.
This Special Issue of International Journal of Environmental Research and Public Health (IJERPH) focuses on the current state of knowledge regarding the economic and clinical burdens related to chronic diseases and the evaluation of medicines used for treating chronic diseases. New research papers, reviews, case reports, and conference papers are welcome for publication in this issue. Other manuscript types accepted include methodological papers, position papers, brief reports, and commentaries.
We will accept manuscripts from studies with different designs, including perspective studies, retrospective studies, and case reports. Here are some examples of topics that could be addressed in this Special Issue:
- Economic or humanistic burdens of chronic diseases;
- Economic evaluations of pharmacological interventions (e.g., medical devices, medications) and behavioral interventions in preventing and treating chronic diseases;
- Budget impact analyses of pharmacological interventions;
- Health technology assessments of new technology;
- Systematic literature reviews of burdens of illness;
- Methodological considerations in the assessment of economic evaluations.
Dr. Z. Kevin Lu
Dr. Jing Yuan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- economic burden
- clinical burden
- medication evaluation
- chronic disease
- cost of illness
- economic evaluations
